Dr. Reddy’s Laboratories Ltd.'s Q1 FY09 Revenue at Rs. 15,038 Million; EBITDA at Rs. 2,710 Million, PAT at Rs. 1,346 Million

HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (NYSE:RDY) today announced its unaudited financial results for the quarter ended June 30, 2008.

MORE ON THIS TOPIC